Hostname: page-component-6bf8c574d5-b4m5d Total loading time: 0 Render date: 2025-02-22T22:30:09.703Z Has data issue: false hasContentIssue false
  • English
  • Français

Protein undernutrition during development and oxidative impairment in the central nervous system (CNS): potential factors in the occurrence of metabolic syndrome and CNS disease

Published online by Cambridge University Press:  08 June 2016

D. J. S. Ferreira ,
D. F. Sellitti  and
C. J. Lagranha
D. J. S. Ferreira
Affiliation:
Neuropsychiatry and Behavior Science Graduate Program, Federal University of Pernambuco, Vitória de Santo Antão, Brazil
D. F. Sellitti
Affiliation:
Department of Medicine, Uniformed Service University of Health Science (USUHS), Bethesda, MD, USA
C. J. Lagranha*
Affiliation:
Neuropsychiatry and Behavior Science Graduate Program, Federal University of Pernambuco, Vitória de Santo Antão, Brazil Laboratory of Biochemistry and Exercise Biochemistry, Department of Physical Education and Sports Science, Federal University of Pernambuco, Vitória de Santo Antão, Brazil
*
*Address for correspondence: C. J. Lagranha, Rua Alto do Reservatório, s/n, Núcleo de Educação Física e Ciências do Esporte, Bela Vista, Vitória de Santo Antão 55608-680, PE, Brazil. (Email [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Mitochondria play a regulatory role in several essential cell processes including cell metabolism, calcium balance and cell viability. In recent years, it has been postulated that mitochondria participate in the pathogenesis of a number of chronic diseases, including central nervous system disorders. Thus, the concept of mitochondrial function now extends far beyond the common view of this organelle as the ‘powerhouse’ of the cell to a new appreciation of the mitochondrion as a transducer of early metabolic insult into chronic disease in later life. In this review, we have attempted to describe some of the associations between nutritional status and mitochondrial function (and dysfunction) during embryonic development with the occurrence of neural oxidative imbalance and neurogenic disease in adulthood.

Keywords

developmental stagemental health/illnessmetabolic syndromemolecular/cellularoutcome/system
Type
Review
Information
Journal of Developmental Origins of Health and Disease , Volume 7 , Issue 5: Themed Issue: Australia/New Zealand 2015 DOHaD Scientific Meeting: Advances and Updates , October 2016 , pp. 513 - 524
Check for updates
Copyright
© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Skulachev, VP. Membrane electricity as a convertible energy currency for the cell. Can J Biochem. 1980; 58, 161–175.Google Scholar
2. Leverve, XM. Mitochondrial function and substrate availability. Crit Care Med. 2007; 35(Suppl. 9), S454–S460.Google Scholar
3. Hagberg, H, Mallard, C, Rousset, CI, Thornton, C. Mitochondria: hub of injury responses in the developing brain. Lancet Neurol. 2014; 13, 217–232.CrossRefGoogle ScholarPubMed
4. Yin, F, Cadenas, E. Mitochondria: the cellular hub of the dynamic coordinated network. Antioxid Redox Signal. 2015; 22, 961–964.Google Scholar
5. Ernster, L, Schatz, G. Mitochondria: a historical review. J Cell Biol. 1981; 91(Pt 2), 227s–255s.Google Scholar
6. Shaughnessy, DT, McAllister, K, Worth, L, et al. Mitochondria, energetics, epigenetics, and cellular responses to stress. Environ Health Perspect. 2014; 122, 1271–1278.Google Scholar
7. Porter, MH, Berdanier, CD. Oxidative phosphorylation: key to life. Diabetes Technol Ther. 2002; 4, 253–254.Google Scholar
8. Sztark, F, Payen, JF, Piriou, V, et al. Cellular energy metabolism: physiologic and pathologic aspects. Ann Fr Anes Reanim. 1999; 18, 261–269.Google Scholar
9. Melov, S. Mitochondrial oxidative stress. Physiologic consequences and potential for a role in aging. Ann N Y Acad Sci. 2000; 908, 219–225.Google Scholar
10. Turrens, JF, Freeman, BA, Levitt, JG, Crapo, JD. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch Biochem Biophys. 1982; 217, 401–410.CrossRefGoogle ScholarPubMed
11. Boveris, A, Oshino, N, Chance, B. The cellular production of hydrogen peroxide. Biochem J. 1972; 128, 617–630.Google Scholar
12. Turrens, JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep. 1997; 17, 3–8.Google Scholar
13. Turrens, JF. Mitochondrial formation of reactive oxygen species. J Physiol. 2003; 552(Pt 2), 335–344.Google Scholar
14. Figueira, TR, Barros, MH, Camargo, AA, et al. Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. Antioxid Redox Signal. 2013; 18, 2029–2074.Google Scholar
15. Andreyev, AY, Kushnareva, YE, Starkov, AA. Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc). 2005; 70, 200–214.Google Scholar
16. Halliwell, B. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 2006; 97, 1634–1658.Google Scholar
17. Halliwell, B. Free radicals and antioxidants: a personal view. Nutr Rev. 1994; 52(Pt 1), 253–265.Google Scholar
18. Halliwell, B. Free radicals and antioxidants: updating a personal view. Nutr Rev. 2012; 70, 257–265.CrossRefGoogle ScholarPubMed
19. Flora, SJ. Role of free radicals and antioxidants in health and disease. Cell Mol Biol (Noisy-le-grand). 2007; 53, 1–2.Google Scholar
20. Jackson, MJ, Papa, S, Bolanos, J, et al. Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol Aspects Med. 2002; 23, 209–285.Google Scholar
21. Conrad, M, Schick, J, Angeli, JP. Glutathione and thioredoxin dependent systems in neurodegenerative disease: what can be learned from reverse genetics in mice. Neurochem Int. 2013; 62, 738–749.Google Scholar
22. Perkins, A, Nelson, KJ, Parsonage, D, Poole, LB, Karplus, PA. Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem Sci. 2015; 40, 435–445.Google Scholar
23. Hirooka, Y. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton Neurosci. 2008; 142, 20–24.Google Scholar
24. Peterson, JR, Sharma, RV, Davisson, RL. Reactive oxygen species in the neuropathogenesis of hypertension. Curr Hypertens Rep. 2006; 8, 232–241.CrossRefGoogle ScholarPubMed
25. Shichiri, M. The role of lipid peroxidation in neurological disorders. J Clin Biochem Nutr. 2014; 54, 151–160.CrossRefGoogle ScholarPubMed
26. Fisher-Wellman, K, Bell, HK, Bloomer, RJ. Oxidative stress and antioxidant defense mechanisms linked to exercise during cardiopulmonary and metabolic disorders. Oxid Med Cell Longev. 2009; 2, 43–51.Google Scholar
27. Powers, SK, Jackson, MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev. 2008; 88, 1243–1276.Google Scholar
28. Li, JM, Shah, AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol. 2004; 287, R1014–R1030.Google Scholar
29. Pritsos, CA. Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system. Chem Biol Interact. 2000; 129, 195–208.Google Scholar
30. Cantu-Medellin, N, Kelley, EE. Xanthine oxidoreductase-catalyzed reactive species generation: a process in critical need of reevaluation. Redox biology. 2013; 1, 353–358.Google Scholar
31. Bedard, K, Krause, KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007; 87, 245–313.Google Scholar
32. Murphy, MP. How mitochondria produce reactive oxygen species. Biochem J. 2009; 417, 1–13.Google Scholar
33. Brand, MD. The sites and topology of mitochondrial superoxide production. Exp Gerontol. 2010; 45, 466–472.CrossRefGoogle ScholarPubMed
34. Quinlan, CL, Orr, AL, Perevoshchikova, IV, et al. Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions. J Biol Chem. 2012; 287, 27255–27264.Google Scholar
35. Fisher-Wellman, KH, Gilliam, LA, Lin, CT, et al. Mitochondrial glutathione depletion reveals a novel role for the pyruvate dehydrogenase complex as a key H2O2-emitting source under conditions of nutrient overload. Free Radic Biol Med. 2013; 65, 1201–1208.Google Scholar
36. Brautigam, CA, Wynn, RM, Chuang, JL, Chuang, DT. Subunit and catalytic component stoichiometries of an in vitro reconstituted human pyruvate dehydrogenase complex. J Biol Chem. 2009; 284, 13086–13098.Google Scholar
37. Ambrus, A, Nemeria, NS, Torocsik, B, et al. Formation of reactive oxygen species by human and bacterial pyruvate and 2-oxoglutarate dehydrogenase multienzyme complexes reconstituted from recombinant components. Free Radic Biol Med. 2015; 89, 642–650.CrossRefGoogle ScholarPubMed
38. Tretter, L, Adam-Vizi, V. Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase. J Neurosci. 2004; 24, 7771–7778.Google Scholar
39. Starkov, AA, Fiskum, G, Chinopoulos, C, et al. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci. 2004; 24, 7779–7788.Google Scholar
40. Orr, AL, Quinlan, CL, Perevoshchikova, IV, Brand, MD. A refined analysis of superoxide production by mitochondrial sn-glycerol 3-phosphate dehydrogenase. J Biol Chem. 2012; 287, 42921–42935.Google Scholar
41. Tretter, L, Takacs, K, Hegedus, V, Adam-Vizi, V. Characteristics of alpha-glycerophosphate-evoked H2O2 generation in brain mitochondria. J Neurochem. 2007; 100, 650–663.Google Scholar
42. St-Pierre, J, Buckingham, JA, Roebuck, SJ, Brand, MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem. 2002; 277, 44784–44790.Google Scholar
43. Perevoshchikova, IV, Quinlan, CL, Orr, AL, Gerencser, AA, Brand, MD. Sites of superoxide and hydrogen peroxide production during fatty acid oxidation in rat skeletal muscle mitochondria. Free Radic Biol Med. 2013; 61, 298–309.Google Scholar
44. Di Lisa, F, Kaludercic, N, Carpi, A, Menabo, R, Giorgio, M. Mitochondria and vascular pathology. Pharmacol Rep. 2009; 61, 123–130.Google Scholar
45. Youdim, MB, Edmondson, D, Tipton, KF. The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci. 2006; 7, 295–309.CrossRefGoogle ScholarPubMed
46. Tipton, KF, Boyce, S, O’Sullivan, J, Davey, GP, Healy, J. Monoamine oxidases: certainties and uncertainties. Curr Med Chem. 2004; 11, 1965–1982.Google Scholar
47. Toninello, A, Salvi, M, Pietrangeli, P, Mondovi, B. Biogenic amines and apoptosis: minireview article. Amino Acids. 2004; 26, 339–343.Google Scholar
48. Herrero, A, Barja, G. Localization of the site of oxygen radical generation inside the complex I of heart and nonsynaptic brain mammalian mitochondria. J Bioenerg Biomembr. 2000; 32, 609–615.Google Scholar
49. Lambert, AJ, Brand, MD. Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane. Biochem J. 2004; 382(Pt 2), 511–517.CrossRefGoogle Scholar
50. Babcock, DF, Herrington, J, Goodwin, PC, Park, YB, Hille, B. Mitochondrial participation in the intracellular Ca2+ network. J Cell Biol. 1997; 136, 833–844.Google Scholar
51. Takeuchi, A, Kim, B, Matsuoka, S. The destiny of Ca(2+) released by mitochondria. J Physiol Sci. 2015; 65, 11–24.Google Scholar
52. Jakob, R, Beutner, G, Sharma, VK, et al. Molecular and functional identification of a mitochondrial ryanodine receptor in neurons. Neurosci Lett. 2014; 575, 7–12.Google Scholar
53. Van Petegem, F. Ryanodine receptors: structure and function. J Biol Chem. 2012; 287, 31624–31632.Google Scholar
54. Csordas, G, Varnai, P, Golenar, T, et al. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol Cell. 2010; 39, 121–132.Google Scholar
55. Csordas, G, Hajnoczky, G. SR/ER-mitochondrial local communication: calcium and ROS. Biochim Biophys Acta. 2009; 1787, 1352–1362.Google Scholar
56. Santo-Domingo, J, Demaurex, N. Calcium uptake mechanisms of mitochondria. Biochim Biophys Acta. 2010; 1797, 907–912.CrossRefGoogle ScholarPubMed
57. Kim, B, Matsuoka, S. Cytoplasmic Na+-dependent modulation of mitochondrial Ca2+ via electrogenic mitochondrial Na+-Ca2+ exchange. J Physiol. 2008; 586, 1683–1697.Google Scholar
58. Saris, NE, Carafoli, E. A historical review of cellular calcium handling, with emphasis on mitochondria. Biochemistry (Mosc). 2005; 70, 187–194.Google Scholar
59. McCormack, JG, Denton, RM. Mitochondrial Ca2+ transport and the role of intramitochondrial Ca2+ in the regulation of energy metabolism. Dev Neurosci. 1993; 15, 165–173.Google Scholar
60. Grijalba, MT, Vercesi, AE, Schreier, S. Ca2+-induced increased lipid packing and domain formation in submitochondrial particles. A possible early step in the mechanism of Ca2+-stimulated generation of reactive oxygen species by the respiratory chain. Biochemistry. 1999; 38, 13279–13287.Google Scholar
61. Castilho, RF, Kowaltowski, AJ, Meinicke, AR, Bechara, EJ, Vercesi, AE. Permeabilization of the inner mitochondrial membrane by Ca2+ ions is stimulated by t-butyl hydroperoxide and mediated by reactive oxygen species generated by mitochondria. Free Radic Biol Med. 1995; 18, 479–486.Google Scholar
62. Rao, VK, Carlson, EA, Yan, SS. Mitochondrial permeability transition pore is a potential drug target for neurodegeneration. Biochim Biophys Acta. 2014; 1842, 1267–1272.CrossRefGoogle ScholarPubMed
63. Grancara, S, Battaglia, V, Martinis, P, et al. Mitochondrial oxidative stress induced by Ca2+ and monoamines: different behaviour of liver and brain mitochondria in undergoing permeability transition. Amino Acids. 2012; 42, 751–759.Google Scholar
64. Quintanilla, RA, Jin, YN, von Bernhardi, R, Johnson, GV. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. Mol Neurodegener. 2013; 8, 45.Google Scholar
65. Frezza, C, Cipolat, S, Martins de Brito, O, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006; 126, 177–189.Google Scholar
66. Mailly, F, Marin, P, Israel, M, Glowinski, J, Premont, J. Increase in external glutamate and NMDA receptor activation contribute to H2O2-induced neuronal apoptosis. J Neurochem. 1999; 73, 1181–1188.Google Scholar
67. Spencer, WA, Jeyabalan, J, Kichambre, S, Gupta, RC. Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species. Free Radic Biol Med. 2011; 50, 139–147.Google Scholar
68. Cardaci, S, Filomeni, G, Rotilio, G, Ciriolo, MR. p38(MAPK)/p53 signalling axis mediates neuronal apoptosis in response to tetrahydrobiopterin-induced oxidative stress and glucose uptake inhibition: implication for neurodegeneration. Biochem J. 2010; 430, 439–451.Google Scholar
69. Zheng, H, Gal, S, Weiner, LM, et al. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition. J Neurochem. 2005; 95, 68–78.Google Scholar
70. Kwan, SW, Bergeron, JM, Abell, CW. Molecular properties of monoamine oxidases A and B. Psychopharmacology (Berl). 1992; 106(Suppl), S1–S5.CrossRefGoogle ScholarPubMed
71. Cobb, CA, Cole, MP. Oxidative and nitrative stress in neurodegeneration. Neurobiol Dis. 2015; 84, 4–21.Google Scholar
72. Pratico, D, Uryu, K, Leight, S, Trojanoswki, JQ, Lee, VM. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci. 2001; 21, 4183–4187.Google Scholar
73. Reed, TT, Pierce, WM, Markesbery, WR, Butterfield, DA. Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD. Brain Res. 2009; 1274, 66–76.Google Scholar
74. Bubber, P, Haroutunian, V, Fisch, G, Blass, JP, Gibson, GE. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol. 2005; 57, 695–703.Google Scholar
75. Chen, X, Stern, D, Yan, SD. Mitochondrial dysfunction and Alzheimer’s disease. Curr Alzheimer Res. 2006; 3, 515–520.Google Scholar
76. Damiano, M, Galvan, L, Deglon, N, Brouillet, E. Mitochondria in Huntington’s disease. Biochim Biophys Acta. 2010; 1802, 52–61.Google Scholar
77. Nasr, P, Gursahani, HI, Pang, Z, et al. Influence of cytosolic and mitochondrial Ca2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid. Neurochem Int. 2003; 43, 89–99.Google Scholar
78. Luo, Y, Hoffer, A, Hoffer, B, Qi, X. Mitochondria: a therapeutic target for Parkinson’s disease? Int J Mol Sci. 2015; 16, 20704–20730.Google Scholar
79. Abdin, AA, Sarhan, NI. Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of alpha-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity. Neurosci Res. 2011; 71, 387–395.Google Scholar
80. Seet, RC, Lee, CY, Lim, EC, et al. Oxidative damage in Parkinson disease: measurement using accurate biomarkers. Free Radic Biol Med. 2010; 48, 560–566.Google Scholar
81. Dutta, R, McDonough, J, Yin, X, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol. 2006; 59, 478–489.Google Scholar
82. Schapira, AH. Complex I: inhibitors, inhibition and neurodegeneration. Exp Neurol. 2010; 224, 331–335.Google Scholar
83. Broadwater, L, Pandit, A, Clements, R, et al. Analysis of the mitochondrial proteome in multiple sclerosis cortex. Biochim Biophys Acta. 2011; 1812, 630–641.Google Scholar
84. Sarti, P, Giuffre, A, Barone, MC, et al. Nitric oxide and cytochrome oxidase: reaction mechanisms from the enzyme to the cell. Free Radic Biol Med. 2003; 34, 509–520.Google Scholar
85. Pollari, E, Goldsteins, G, Bart, G, Koistinaho, J, Giniatullin, R. The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front Cell Neurosci. 2014; 8, 131.Google Scholar
86. Robberecht, W, Philips, T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci. 2013; 14, 248–264.Google Scholar
87. Beal, MF, Ferrante, RJ, Browne, SE, et al. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol. 1997; 42, 644–654.Google Scholar
88. Estevez, AG, Crow, JP, Sampson, JB, et al. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science. 1999; 286, 2498–2500.Google Scholar
89. Harraz, MM, Marden, JJ, Zhou, W, et al. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest. 2008; 118, 659–670.Google Scholar
90. Paravicini, TM, Touyz, RM. Redox signaling in hypertension. Cardiovasc Res. 2006; 71, 247–258.Google Scholar
91. Chan, SH, Chan, JY. Brain stem NOS and ROS in neural mechanisms of hypertension. Antioxid Redox Signal. 2013; 20, 146–163.Google Scholar
92. Hirooka, Y, Kishi, T, Sakai, K, Takeshita, A, Sunagawa, K. Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension. Am J Physiol Regul Integr Comp Physiol. 2011; 300, R818–R826.Google Scholar
93. Chan, SH, Tai, MH, Li, CY, Chan, JY. Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic Biol Med. 2006; 40, 2028–2039.Google Scholar
94. Chan, SH, Wu, KL, Chang, AY, Tai, MH, Chan, JY. Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension. 2009; 53, 217–227.Google Scholar
95. Chan, SH, Wu, CA, Wu, KL, et al. Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension. Circ Res. 2009; 105, 886–896.Google Scholar
96. Chan, SH, Chan, JY. Angiotensin-generated reactive oxygen species in brain and pathogenesis of cardiovascular diseases. Antioxid Redox Signal. 2013; 19, 1074–1084.Google Scholar
97. Nozoe, M, Hirooka, Y, Koga, Y, et al. Inhibition of Rac1-derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats. Hypertension. 2007; 50, 62–68.CrossRefGoogle ScholarPubMed
98. Godfrey, KM, Gluckman, PD, Hanson, MA. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metab. 2010; 21, 199–205.CrossRefGoogle ScholarPubMed
99. Lucas, A, Fewtrell, MS, Cole, TJ. Fetal origins of adult disease-the hypothesis revisited. BMJ. 1999; 319, 245–249.Google Scholar
100. Colombo, J. The critical period concept: research, methodology, and theoretical issues. Psychol Bull. 1982; 91, 260–275.CrossRefGoogle ScholarPubMed
101. Hales, CN, Barker, DJ, Clark, PM, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991; 303, 1019–1022.CrossRefGoogle ScholarPubMed
102. Pigliucci, M. Developmental phenotypic plasticity: where internal programming meets the external environment. Curr Opin Plant Biol. 1998; 1, 87–91.CrossRefGoogle ScholarPubMed
103. Khan, I, Dekou, V, Hanson, M, Poston, L, Taylor, P. Predictive adaptive responses to maternal high-fat diet prevent endothelial dysfunction but not hypertension in adult rat offspring. Circulation. 2004; 110, 1097–1102.Google Scholar
104. Hanson, M, Gluckman, P. Endothelial dysfunction and cardiovascular disease: the role of predictive adaptive responses. Heart. 2005; 91, 864–866.Google Scholar
105. Nettle, D, Frankenhuis, WE, Rickard, IJ. The evolution of predictive adaptive responses in human life history. Proc Biol Sci. 2013; 280, 20131343.Google Scholar
106. Wells, JC. The thrifty phenotype hypothesis: thrifty offspring or thrifty mother? J Theor Biol. 2003; 221, 143–161.Google Scholar
107. Wells, JC. Flaws in the theory of predictive adaptive responses. Trends Endocrinol Metab. 2007; 18, 331–337.Google Scholar
108. Wells, JC. The thrifty phenotype: an adaptation in growth or metabolism? Am J Hum Biol. 2011; 23, 65–75.Google Scholar
109. Bale, TL. Epigenetic and transgenerational reprogramming of brain development. Nat Rev Neurosci. 2015; 16, 332–344.Google Scholar
110. Martin-Gronert, MS, Ozanne, SE. Mechanisms underlying the developmental origins of disease. Rev Endocr Metab Disord. 2012; 13, 85–92.Google Scholar
111. Martinez, SR, Gay, MS, Zhang, L. Epigenetic mechanisms in heart development and disease. Drug Discov Today. 2015; 20, 799–811.Google Scholar
112. Ozanne, SE, Constancia, M. Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat Clin Pract Endocrinol Metab. 2007; 3, 539–546.Google Scholar
113. Luo, ZC, Fraser, WD, Julien, P, et al. Tracing the origins of ‘fetal origins’ of adult diseases: programming by oxidative stress? Med Hypotheses. 2006; 66, 38–44.Google Scholar
114. Mitchell, M, Schulz, SL, Armstrong, DT, Lane, M. Metabolic and mitochondrial dysfunction in early mouse embryos following maternal dietary protein intervention. Biol Reprod. 2009; 80, 622–630.Google Scholar
115. Theys, N, Clippe, A, Bouckenooghe, T, Reusens, B, Remacle, C. Early low protein diet aggravates unbalance between antioxidant enzymes leading to islet dysfunction. PLoS One. 2009; 4, e6110.Google Scholar
116. Tarry-Adkins, JL, Chen, JH, Jones, RH, Smith, NH, Ozanne, SE. Poor maternal nutrition leads to alterations in oxidative stress, antioxidant defense capacity, and markers of fibrosis in rat islets: potential underlying mechanisms for development of the diabetic phenotype in later life. FASEB J. 2010; 24, 2762–2771.Google Scholar
117. Tarry-Adkins, JL, Martin-Gronert, MS, Fernandez-Twinn, DS, et al. Poor maternal nutrition followed by accelerated postnatal growth leads to alterations in DNA damage and repair, oxidative and nitrosative stress, and oxidative defense capacity in rat heart. FASEB J. 2013; 27, 379–390.Google Scholar
118. McGaughy, JA, Amaral, AC, Rushmore, RJ, et al. Prenatal malnutrition leads to deficits in attentional set shifting and decreases metabolic activity in prefrontal subregions that control executive function. Dev Neurosci. 2014; 36, 532–541.Google Scholar
119. Duran, P, Galler, JR, Cintra, L, Tonkiss, J. Prenatal malnutrition and sleep states in adult rats: effects of restraint stress. Physiol Behav. 2006; 89, 156–163.Google Scholar
120. Faa, G, Marcialis, MA, Ravarino, A, et al. Fetal programming of the human brain: is there a link with insurgence of neurodegenerative disorders in adulthood? Curr Med Chem. 2014; 21, 3854–3876.Google Scholar
121. Airey, CJ, Smith, PJ, Restall, K, et al. Maternal undernutrition affects neurogenesis in the foetal mouse brain. Int J Dev Neurosci. 2015; 47(Pt A), 72.Google Scholar
122. Field, ME, Anthony, RV, Engle, TE, et al. Duration of maternal undernutrition differentially alters fetal growth and hormone concentrations. Domest Anim Endocrinol. 2015; 51, 1–7.Google Scholar
123. Partadiredja, G, Worrall, S, Bedi, KS. Early life undernutrition alters the level of reduced glutathione but not the activity levels of reactive oxygen species enzymes or lipid peroxidation in the mouse forebrain. Brain Res. 2009; 1285, 22–29.Google Scholar
124. Partadiredja, G, Worrall, S, Simpson, R, Bedi, KS. Pre-weaning undernutrition alters the expression levels of reactive oxygen species enzymes but not their activity levels or lipid peroxidation in the rat brain. Brain Res. 2008; 1222, 69–78.CrossRefGoogle ScholarPubMed
125. Franco, MC, Akamine, EH, Reboucas, N, et al. Long-term effects of intrauterine malnutrition on vascular function in female offspring: implications of oxidative stress. Life Sci. 2007; 80, 709–715.Google Scholar
126. Franco Mdo, C, Dantas, AP, Akamine, EH, et al. Enhanced oxidative stress as a potential mechanism underlying the programming of hypertension in utero. J Cardiovasc Pharmacol. 2002; 40, 501–509.Google Scholar
127. Gupta, P, Narang, M, Banerjee, BD, Basu, S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case control study. BMC Pediatr. 2004; 4, 14.Google Scholar
128. Gveric-Ahmetasevic, S, Sunjic, SB, Skala, H, et al. Oxidative stress in small-for-gestational age (SGA) term newborns and their mothers. Free Radic Res. 2009; 43, 376–384.Google Scholar
129. Tonkiss, J, Galler, J, Morgane, PJ, Bronzino, JD, Austin-LaFrance, RJ. Prenatal protein malnutrition and postnatal brain function. Ann N Y Acad Sci. 1993; 678, 215–227.Google Scholar
130. Morgane, PJ, Austin-LaFrance, R, Bronzino, J, et al. Prenatal malnutrition and development of the brain. Neurosci Biobehav Rev. 1993; 17, 91–128.Google Scholar
131. Morgane, PJ, Mokler, DJ, Galler, JR. Effects of prenatal protein malnutrition on the hippocampal formation. Neurosci Biobehav Rev. 2002; 26, 471–483.Google Scholar
132. Al-Gubory, KH, Fowler, PA, Garrel, C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol. 2010; 42, 1634–1650.Google Scholar
133. Bonatto, F, Polydoro, M, Andrades, ME, et al. Effect of protein malnutrition on redox state of the hippocampus of rat. Brain Res. 2005; 1042, 17–22.Google Scholar
134. Halliwell, B. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Pathol. 1989; 70, 737–757.Google Scholar
135. Jackson, JH, Schraufstatter, IU, Hyslop, PA, et al. Role of hydroxyl radical in DNA damage. Transactions of the Association of American Physicians. 1987; 100, 147–157.Google Scholar
136. Gutteridge, JM, Wilkins, S. Copper salt-dependent hydroxyl radical formation. Damage to proteins acting as antioxidants. Biochim Biophys Acta. 1983; 759, 38–41.Google Scholar
137. Bonatto, F, Polydoro, M, Andrades, ME, et al. Effects of maternal protein malnutrition on oxidative markers in the young rat cortex and cerebellum. Neurosci Lett. 2006; 406, 281–284.Google Scholar
138. Alvarez, B, Radi, R. Peroxynitrite reactivity with amino acids and proteins. Amino Acids. 2003; 25, 295–311.CrossRefGoogle ScholarPubMed
139. Feoli, AM, Siqueira, IR, Almeida, L, et al. Effects of protein malnutrition on oxidative status in rat brain. Nutrition. 2006; 22, 160–165.Google Scholar
140. Voog, L, Eriksson, T. Toluene-induced decrease in rat plasma concentrations of tyrosine and tryptophan. Acta Pharmacol Toxicol. 1984; 54, 151–153.Google Scholar
141. Tatli, M, Guzel, A, Kizil, G, et al. Comparison of the effects of maternal protein malnutrition and intrauterine growth restriction on redox state of central nervous system in offspring rats. Brain Res. 2007; 1156, 21–30.Google Scholar
142. Ferreira, DJ, Liu, Y, Fernandes, MP, Lagranha, CJ. Perinatal low-protein diet alters brainstem antioxidant metabolism in adult offspring. Nutr Neurosci. 2015; doi:10.1179/1476830515Y.0000000030, in press.Google ScholarPubMed
143. Cardoso, LM, Colombari, DS, Menani, JV, et al. Cardiovascular responses to hydrogen peroxide into the nucleus tractus solitarius. Am J Physiol Regul Integr Comp Physiol. 2009; 297, R462–R469.Google Scholar
144. Chan, SH, Chan, JY. Brain stem oxidative stress and its associated signaling in the regulation of sympathetic vasomotor tone. J Appl Physiol (1985). 2012; 113, 1921–1928.Google Scholar
145. Muzzo, S, Gregory, T, Gardner, LI. Oxygen consumption by brain mitochondria of rats malnourished in utero. J Nutr. 1973; 103, 314–317.Google Scholar
146. Alamy, M, Bengelloun, WA. Malnutrition and brain development: an analysis of the effects of inadequate diet during different stages of life in rat. Neurosci Biobehav Rev. 2012; 36, 1463–1480.Google Scholar
147. Mokler, DJ, Galler, JR, Morgane, PJ. Modulation of 5-HT release in the hippocampus of 30-day-old rats exposed in utero to protein malnutrition. Brain Res Dev Brain Res. 2003; 142, 203–208.Google Scholar
148. Olorunsogo, OO. Changes in brain mitochondrial bioenergetics in protein-deficient rats. Br J Exp Pathol. 1989; 70, 607–619.Google Scholar